Haloperidol
Oral
Intramuscular
Class
Antipsychotics
Subclass
Butyrophenones
Substance name
Haloperidol
Common formulations
Solution, Tablet
See also
Haloperidol decanoate LA (Haldol®)
Dosage and administration
Adults patients
Treatment
Psychotic disorders • Moderate symptoms
Psychotic disorders • Severe symptoms
Tourette's syndrome • Moderate symptoms
Tourette's syndrome • Severe symptoms
Delirium • Off-label
Delirium in patients with advanced cancer • Off-label
Nausea and vomiting in patients with advanced cancer • Off-label
Adjunctive treatment
Adjunctive treatment for alcohol withdrawal syndrome • Off-label
Other off-label uses
Indications for use
Labeled indications
Adults
Off-label indications
Adults
Safety risks
Boxed warnings
Increased risk of mortality
Contraindications
Hypersensitivity to haloperidol or its components
Dementia with Lewy Bodies
Severe toxic CNS depression or comatose states from any cause
Warnings and precautions
Cerebrovascular events
CNS depression
Decreased WBC count, decreased blood neutrophil count
Depression
Dyskinesia
Encephalopathy
Extrapyramidal signs
Falls
Hypotension, angina pectoris
Increased serum haloperidol levels
Increased serum prolactin
Neuroleptic malignant syndrome
Neurotoxicity
Prolonged QT interval, torsade de pointes
Seizure
Somnolence, motor impairment
Tardive dyskinesia
Specific populations
Renal impairment
eGFR 0-90 mL/min/1.73 m²
Renal replacement therapy
Peritoneal dialysis
Hepatic impairment
Any severity
Pregnancy and breastfeeding
Pregnancy
All trimesters • Australia Category: C
Adverse reactions
Unknown frequency
Interactions
Drug(s)
Check Interactions
Reset
What did you think about this content?
Sign up for free to access the full drug resource